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Abstract
Background: Postpartum depression (PPD) is one of the most common complications of
childbirth, affecting approximately 10-20% of mothers within the child’s first year of life with
negative impact on both mother and child. Pediatric primary care providers have frequent contact
over the infant’s first year of life. The American Academy of Pediatrics (AAP) recommends
screening mothers for PPD at the 1, 2, 4, and 6-month well-baby visits, yet due to barriers,
pediatric providers are not consistently screening for PPD. Barriers include lack of preparedness
and knowledge of resources, and inadequate time.
Aims of Service Change: To improve pediatric provider preparedness to screen for PPD
at a large multi-site pediatric group practice in Southern California and lead to increased
screening, detection, and treatment of PPD.
Details of Innovation: The core intervention was provider education regarding
recommendations for postpartum depression screening. Provider education also included
provider responsibility in identifying PPD, community resources, and an overview of PPD
diagnostic criteria. This project assessed provider preparedness using a pre-post education online
anonymous survey.
Outcome: Implementation of provider education increased self-reported preparedness to
screen for PPD at well-baby visits with an increase of average score in all categories. Knowledge
of resources and provider confidence had the most substantial increases.
Discussion: Implementing provider education regarding screening for PPD at well-baby
visits is a simple and cost-effective intervention. This leads to improved provider preparedness,
potential increased identification of PPD in mothers, and improved overall outcomes for mothers
and babies.
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Description of the Clinical Problem
Postpartum depression (PPD) is defined as major depressive disorder that occurs in
women during the perinatal or immediate postnatal period (United States Preventive Services
Task Force, 2019). Postpartum depression (PPD) is one of the most common complications of
childbirth, estimated to affect between 10-20% of childbearing women (Friedman et al., 2016).
Although studies estimate up to 20% of women experience PPD, numbers are suspected to be
much higher, as many cases go undetected (Friedman et al., 2016). Postpartum depression can
present up to a year after childbirth, but most cases occur within 6 months postpartum (Friedman
et al., 2016).
If postpartum depression is left untreated, serious consequences can arise including the
mother’s ability to bond and engage with her child (Friedman et al., 2016). Lack of engagement
and bonding between the pair can lead to impaired cognitive, language and emotional
development in the child, along with other health problems (Waldrop et al., 2018). Early
detection and intervention of PPD can reduce the risks of negative outcomes for both mother and
child (Waldrop et al., 2018). For this reason, it is imperative that mothers are screened for
postpartum depression during the postnatal period (Waldrop et al., 2018).
Pediatric primary care providers are in a valuable position to screen for PPD, as they have
frequent contact with mothers over the infant’s first year of life (Waldrop et al., 2018) The
American Academy of Pediatrics (AAP) recommends screening for PPD at the 1, 2, 4, and 6month well-baby visits (Earls et al., 2019). A recent review of literature showed that only about
55% of providers screened for PPD, with pediatric providers ranking the least likely to screen for
PPD (Goldin Evans et al., 2015). Barriers to screening for PPD include lack of preparedness,
inadequate time, and attitude of the pediatric provider (Goldin Evans et al., 2015). The majority
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of pediatric providers indicated that they believed screening for PPD was their responsibility, but
lacked confidence in their ability to recognize and manage it (Goldin Evans et al., 2015).
Description of the Project
The proposed evidence-based practice change was an educational intervention that aimed
to better prepare pediatric providers to screen for PPD in the pediatric primary care setting. The
Doctor of Nursing Practice Student worked with a pediatrician at a large, multi-site pediatric
primary care clinic in Southern California to provide a one-time education session regarding
screening for PPD at the 1, 2, 4 and 6-month well-baby visits. The physician who researched,
constructed, and gave the lecture is a pediatrician at the group with special interest in maternal
depression and postpartum health. The principal investigator (PI) performed a literature review
and created an 8-question survey in order to measure provider preparedness to screen for PPD
prior to the education. The survey collected demographic information, as well as used a 5-point
Likert Scale to measure five main categories of provider preparedness to screen for PPD. These
categories included perceived responsibility of screening for PPD, self-reported frequency of
screening for PPD, confidence in identifying PPD, knowledge of resources for women with PPD,
and current time constraints with well-baby visits. Providers also had to opportunity to identify
barriers to screening for PPD at well-baby visits. One week prior to the education, the survey
was emailed to all eligible pediatric providers in the practice, including physicians, nurse
practitioners, and physician assistants, to complete anonymously.
The one-time education included a PowerPoint that presented an overview of the PPD
diagnosis and the standardized tools used to screen for it. This clinic group decided to
incorporate the Patient Health Questionaire-9 (PHQ-9) (Pfizer, 1999) into the 1, 2, 4, and 6month well-baby visits, as this screen was already integrated into their charting system. The
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education then reviewed available PPD resources and referral procedures for positive diagnoses
of PPD. The lecture went on to review the impact of untreated PPD on both child and mother and
discussed the PPD screening opportunity that presents itself in pediatric primary care offices.
The same survey administered pre-education was then re-emailed to every provider in the
company immediately post education.
Evidence Based Practice Model
The Johns Hopkins Nursing Evidence-based Practice Model and Guidelines (JH-NEBP)
“steadfastly dedicated to the advancement of evidence-based practice (EBP) and to frontline
nurses who strive daily to improve patient care outcomes through the translation of evidence into
practice” (Dang & Dearholt, 2017, p.xii). The JH-NEBP Model is nursing-oriented and focuses
on “inquiry, practice and learning” (Dang & Dearholt, 2017, p. 36). The core process utilized by
the JH-NEBP Model is the practice question, evidence and translation (PET) process (Dang &
Dearholt, 2017). This process provides a systematic approach for identifying clinical questions
that lack evidence-based research, appraising the existing research, and safely implementing that
research into clinical practice (Dang & Dearholt, 2017). This project identifies the lack of
postpartum depression (PPD) screening in new mothers as a clinical practice problem. There is
current evidence that shows that PPD screening in pediatric primary care can result in an
increase in PPD identification and early intervention, so why are pediatric providers not
screening for PPD more frequently (Earls & Health, 2010)? The evidence points to a lack of
preparedness within the pediatric provider community. The JH-NEBP Model provided the
framework for implementing the current research on provider preparedness for PPD screening
and translating it in the pediatric primary care setting using the PET process (Dang & Dearholt,
2017).
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Synthesis of the Evidence
A literature review was conducted to find evidence to support the method of self-reported
survey in order to assess provider preparedness to screen for PPD. Included was review of
evidence to support the use of provider education to better prepare providers to screen for PPD.
The following databases were used as search engines: CINAHL and PubMed. The following
keywords were used: “postpartum depression screening”, “postpartum depression screening
pediatric”, “perinatal depression”, “screening pediatrics”, “pediatrics AND depression”,
“postpartum depression screening pediatric primary care”, and “attitude, postpartum depression
screening”. The filters used in the search engines include free full text, English, humans,
published between 2010-2020.
Postpartum depression screening pediatrics yielded 13 results, 2 of which were saved for
further review. Postpartum depression screening produced 87 results, and 5 articles were saved
for review. Attitude, postpartum depression screening yielded 77 results, and 3 articles were
saved. The search criteria were broadened to extend to articles written from 2000-2020. This
search yielded three additional articles, which were saved for further review. After narrowing the
results based off duplicate articles, studies not based in the United States, and relevance of article
content, 10 articles were selected for use. The PI referenced the PHQ-9 screening tool in
formulating evidence-based solutions (Pfizer, 1999). In addition, the American Academy of
Pediatrics website, which recommends screening for PPD at well-baby visits, was used as
evidence (American Association of Pediatrics, 2021). The United States Preventative Services
Task Force (USPSTF) recommendations on screening for PPD were also used to support
evidence-based solutions (United States Preventive Services Task Force, 2019). The Johns
Hopkins Nursing Evidence Level and Quality Guide was used to grade the evidence (Dang &
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Dearholt, 2017). The Johns Hopkins Nursing Evidence Level and Quality Guide assigns articles
a level, ranked I-V, based on the type of study that was conducted (Dang & Dearholt, 2017).
Level I articles include experimental studies, RCTs, and systemic reviews of RCTs (Dang &
Dearholt, 2017). Level II-IV articles include quasi-experimental, non-experimental, qualitative
studies, and expert opinions (Dang & Dearholt, 2017). Level V articles include non-research data
(Dang & Dearholt, 2017). The Johns Hopkins Nursing Evidence Level and Quality Guide also
assigns evidence quality grades between A-C (Dang & Dearholt, 2017). Grade A articles include
high quality evidence, grade B includes good quality evidence, and grade C includes low quality
evidence (Dang & Dearholt, 2017). Based on the Johns Hopkins Nursing Evidence Level and
Quality Guide, the literature review provided 7 level III, grade A/B articles and 3 level IV, grade
A articles (Dang & Dearholt, 2017).
The evidence shows that women are being underdiagnosed and therefore, undertreated
for PPD (Delatte et al., 2009). Untreated PPD can lead to poor health outcomes in the mother,
but can also cause delays in development, cognition and language for the child (Waldrop et al.,
2018). Screening for PPD in the pediatric primary care is a feasible and effective way to increase
detection rates of PPD, given the amount of contact that pediatric providers have with new
mothers (Zee-van den Berg et al., 2017). Although pediatric providers have an important
opportunity to screen for PPD, one national survey showed that less than half of pediatricians
were screening on a regular basis (Olson et al., 2002). It is important to assess attitude about,
confidence in, and frequency of screening for PPD for pediatric providers in order to evaluate the
areas that are lacking education (Olson et al., 2002).
An email survey of obstetrics providers at a large hospital was able to assess confidence
levels of diagnosing, managing, and referring PPD (Delatte et al., 2009). The study also showed
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that presenting the survey results about PPD increased overall provider awareness to screen for
PPD (Delatte et al., 2009). Another national mail survey was able to assess 437 obstetric
residents attitudes in screening for PPD, showing that self-report surveys can adequately evaluate
provider attitude and potentially determine barriers to care (Dietrich et al., 2003).
One study performed at a large, urban pediatric practice was able to assess provider
preparedness and attitude for screening for PPD in the pediatric outpatient setting (Friedman et
al., 2016). An educational intervention on PPD screening was given to all pediatric providers
(Friedman et al., 2016). Prior to the educational intervention, a 5- point Likert scale preeducational survey was sent out in order to assess comfort of screening for PPD, self-reported
screening and referring for PPD, and general knowledge of PPD (Friedman et al., 2016). The
same email survey was sent out to all providers 2 months post educational intervention
(Friedman et al., 2016). Based on self-report, knowledge of PPD, frequency of screening, and
confidence in diagnosis increased after the educational intervention (Friedman et al., 2016).
A literature review performed by Goldin Evans et al., found that pediatricians were the
least confident in their skills to recognize PPD, even though 75% reported responsibility to do so
(Goldin Evans et al., 2015). A policy statement published by the AAP, formulated by the
Committee on Psychosocial Aspects of Child and Family Health, recommends that all pediatric
providers should receive education regarding screening for PPD in the primary care setting
(Earls et al., 2019).
The literature review supported the use of an educational intervention to better prepare
pediatric providers to screen for PPD. In addition, the literature review demonstrated the use of
self-report survey as a valid way to assess provider preparedness to screen for PPD.
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Stakeholder Identification and Implementation Barriers
The large medical group has taken initiative to incorporate best practice for mental health
into the policies and procedures. The mental health director of the practice was in support of
increasing screening for PPD at well-baby visits, making her a valuable stakeholder in this
project. Additionally, the student’s clinical mentor is a passionate advocate for maternal health
and important stakeholder in the project. The Chief Medical Officer (CMO) also showed his
support of the educational intervention via email and letter of support. Frequent check-ins with
the mental health director, CMO, and clinical mentor helped facilitate a smooth implementation.
Potential barriers for implementing the project were identified, including the need to
present the educational intervention virtually due to the COVID-19 pandemic. The presenting
physician requested all video cameras be turned on and questions be directed toward the chat box
to maintain focus and flow during the presentation. The presenting physician also asked
engaging questions to the participants in order to boost participation.
Another potential barrier that was identified was provider resistance to change. The
presenting physician directly laid out the specific changes that would be implemented throughout
the practice after the PPD educational intervention, including adding PHQ-9 screenings to wellbaby visits that fit certain criteria. Resources were also populated into a smart set to make these
visits as efficient as possible.
Project Approval
The Chief Medical Officer (CMO) of the medical group approved the educational
intervention on April 10th, 2020. The online survey generator, Survey Monkey, was utilized to
design an 8-question survey, which was subsequently approved by the clinical mentor of the
student and the Chief Medical Officer on April 13th, 2020. Due to the fact that the pediatric
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practice does not have an IRB, a letter of support from the CMO was received on April 10th,
2020. IRB exempt status was received from the University of San Diego on April 14th, 2020.
Project Methods and Implementation
Once approval was received from the pediatric practice and USD IRB, the electronic
survey was created. The decision to use this online survey generator was at the recommendation
of the clinical mentor and faculty advisor. Based off the literature review, the principal
investigator (PI) of this project generated 8 questions to assess provider preparedness for
postpartum depression screening in well-baby visits. The questions used a 5-point Likert Scale
and are outlined in Table 1. The 5-point Likert scale asked the survey participants to rank their
agreeance of the statement on a scale of strongly disagree, somewhat disagree, neutral, somewhat
agree, and strongly agree. The anonymous survey was sent to providers one week, three days and
one day prior to the planned educational presentation. The identities of the survey respondents
were kept anonymous. The pre-educational survey yielded 131 responses.
Due to the COVID-19 pandemic, the educational session was held electronically, and all
participants were able to see a PowerPoint presentation. The lecture discussed the diagnostic
parameters surrounding PPD diagnosis, importance of screening for PPD in pediatric primary
care, effects of PPD on children, tools utilized to screen for PPD, and future implementations of
screening protocols for the practice. The education session lasted about 1 hour, which included
time for questions.
Directly after the presentation, the same survey was emailed out to all providers at the
practice, regardless of attendance of the education session. Participants were encouraged to
respond to the survey in order to help with data analysis for the project. The post-education
survey yielded a 70% response rate with 92 responses.
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Process Indicators
Process indicators for the project included number of survey responses prior to and
directly after the educational intervention. Several emails were sent out to all providers at the
pediatric practice in order to increase the number of responses prior to the education. Preeducation survey numbers were important in order to assess the self-reported level of provider
preparedness to screen for PPD at well-baby visits and as a needs-assessment for the areas that
providers felt least confident in. The presenting physician and PI were able to use these survey
results to evaluate which areas to focus on during the presentation.
Outcome Indicators
Outcome indicators consisted of number of participants who attended the educational
intervention, number of participants who took the post-education survey, and average change in
Likert scale rankings in the post-survey analysis. In agreeance with the IRB exempt status, the
participants were kept anonymous. For this reason, it was not possible to directly compare pre
and post survey results for each individual participant. Instead, an average Likert score was
calculated for each question in both pre and post education surveys. An increase in the average
score indicated an increase in preparedness in that category.
Data Analysis
Data collection for the project began with administration of the pre-educational survey
that was emailed to all eligible providers at the pediatric practice. The survey utilized a 5-point
Likert scale to capture provider attitude towards various statements about postpartum depression
screening. The survey-takers were given a statement regarding attitude, comfort level or
knowledge of postpartum depression screening. The survey-takers rated their agreement with the
statement on a scale of 1-5, with 1 being “strongly disagree” and 5 being “strongly agree”. There
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were 131 responses to the pre-education survey. Data analysis identified the areas that providers
were in lowest level of agreement based on the Likert scale score. The average score for each
statement was calculated in order to identify areas that needed the most focus during the
educational session.
As outlined in Figure 1, question 3, which assessed provider self-reported responsibility
to screen for PPD, showed an average Likert score of 4.2. Question 4, which assessed selfreported screening for PPD, showed an average Likert score of 2.97. Question 5, which assessed
provider confidence in screening for PPD, had an average Likert score of 3.09. The lowest
average Likert score of 2.56 was Question 6, which asked providers about knowledge of
resources and referrals for mothers who screen positive for PPD. Lastly, Question 7, which asked
about adequate time to screen for PPD, showed an average Likert score of 2.73. The average
Likert scores for each question were calculated and used to determine content of the educational
session.
Immediately after the 1-hour education session, the same survey was emailed out to all
providers at the practice. Due to the nature of the project, the respondents were kept anonymous,
and therefore, it was impossible to link individual responses. The Likert scores for each
statement in the pre and post education surveys were averaged and compared. There were
increases in average scores in all categories in the post-education survey. The average posteducation scores increased by 0.5%, 4.4%, 21%, 41%, and 23%, respectively (See Figure 1).
Additionally, the percentage of providers who marked each Likert scale rating pre and post
education were compared.
The most significant increases in scores were in the “confidence” and “knowledge of
resource” categories. Knowledge of resources (Question 5) had increases in the “somewhat
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agree” and “strongly agree” rankings. The “strongly agree” ranking increased by 13%, and the
“somewhat agree” ranking increased by 16%. Inversely, the percentage of providers who marked
“somewhat disagree” decreased by 20%. Provider confidence (Question 6) showed a 17%
increase in the “strongly agree” ranking, and a 15% increase in the “somewhat agree” ranking.
The “strongly disagree” ranking decreased by 23%.
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Table 1
Questions included in the survey
Question 1
Question 2
Question 3
Question 4
Question 5
Question 6
Question 7
Question 8

Please specify your role at the clinic.
Please specify years of practice in your role.
I believe it is my responsibility to identify postpartum depression.
I screen mothers of newborns for postpartum depression at the well-baby visits
between 2 weeks- 6 months.
I feel confident in my ability to screen for postpartum depression.
I am aware of the resources that exist and where to refer a mother if she screens
positive for postpartum depression.
I have adequate time to screen newborn mothers for postpartum depression at wellbaby visits.
Which of the following are barriers to screening for postpartum depression at wellbaby visits? Please select all the apply.

Figure 1
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Figure 2
Percentages Pre and Post Education for Provider Confidence
Q5: I feel confident in my ability to identify postpartum
depression.
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Figure 3
Percentages Pre and Post Education for Knowledge of Resources
Q6: I am aware of what resources exist and where to refer a mother
if she screens positive for postpartum depression.
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Implications for Clinical Practice
Clinical implications for this project include increased provider preparedness for PPD
screening, overall better outcomes for patients and families, and potential for the participating
providers to receive continuing education credit for completing the education. Based on the
analysis of the pre and post education survey results, providers who completed the education had
self-reported increase in all categories of assessment. Using this information, it can be concluded
that providers had an increase in self-reported preparedness to screen for PPD during well-baby
visits. With increase provider preparedness, there will likely be an increase in screening of new
mothers at well-baby visits. Increased screening can lead to increased identification and
treatment of mothers who have PPD, which can lead to overall better outcomes for both mothers
and children. The opportunity to receive continuing education credit for attending the education
may be possible, pending approval from the certifying organizations.
Cost Benefit Analysis
The costs to complete this project were relatively low. A subscription to the online survey
system was purchased for the pre and post surveys. An additional factor considered in the cost of
the project was provider time and associated cost to complete the surveys and attend the
education session. Based on an average pediatrician salary in California, the estimated total cost
was $7,266 for 131 providers to participate in both surveys and the educational session. There
are no additional costs from training or educating ancillary staff, as the PHQ-9 is incorporated
into the electronic tablet system that the practice currently uses.
Estimated benefits for this project include pediatric provider’s ability to bill for
administering the screening and counseling mothers about postpartum depression. Additionally,
there is an estimated cost avoidance of $10,182 per remission of severe PPD in new mothers
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(Wilkinson et al., 2017). Based on known incidence of PPD, it is estimated that the practices
could see an average 1 mother with severe PPD per month, putting the cost avoidance to the
health care system at approximately $122,184 annually. In addition to monetary benefits, several
service improvement benefits were identified. Patients and families are receiving improved care
services with provider preparedness to screen for PPD at well-baby visits. Increased screening
and identification of PPD can prevent complications in the child associated with poor maternal
bonding such as developmental delays, anxiety, and emotional development (Waldrop et al.,
2018).
According to these estimates, for every dollar spent there is a $16.60 cost savings
(avoidance of health care costs) by implementing this project. This calculates to a 1,558% return
on investment (ROI) for the practice and associated health care systems.
Project Dissemination
This project will be presented at the Western Institute of Nursing (WIN) virtual
conference on April 14-17th, 2021. In addition to presenting at the WIN conference, the project
was presented at the National Association for Pediatric Nurse Practitioners (NAPNAP) local San
Diego chapter meeting. Pediatric Nurse Practitioners who practice at various locations in the San
Diego area attended this presentation. A stakeholder presentation was conducted on March 31,
2021 with the clinical mentor, clinical faculty, and other clinic providers in attendance. A poster
presentation with summary was presented to the University of San Diego students and faculty at
Doctor of Nursing Practice Presentation Day, conducted virtually on March 4, 2021.
Conclusions
Pediatric primary care providers are in a valuable position to screen new mothers for PPD
due to frequent well-baby visits during the child’s first year of life. Screening for PPD is
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recommended by the AAP at the 1, 2, 4, and 6-month well-baby visits. Although pediatric
providers have the opportunity to screen for PPD, many do not screen on a consistent basis.
Many pediatric providers do not feel adequately prepared to screen for PPD due to lack of
confidence, knowledge of resources, and time constraints during well-baby visits. The evidence
supports provider education as a simple yet effective tool in increasing provider preparedness for
PPD screening. Implementation of a one-time education session regarding the AAP
recommendations to screen for PPD, existing resources for mothers who screen positive for PPD,
and future implications for incorporating PPD screening into well-baby visits increased selfreported provider confidence and overall preparedness for screening for PPD. Increased
screening for PPD can lead to increased identification and early intervention for new mothers,
which will benefit both the mother and child’s overall health and wellbeing.
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